bpc-157 fibromyalgia clinical trial Pure Delayed Release, 60 Capsules If BPC-157 worked as well

(SOD, )

Unlike many peptides that are unstable in physiological conditions, BPC-157 has demonstrated remarkable stability in both acidic (gastric) and neutral (plasma) environments in published research a property that has made it one of the most studied peptides for tissue repair across more than 100 independent pre-clinical investigations

Protocol Used: 0.25 mg BPC-157 subcutaneous injection daily for 6 weeks, administered 2 inches proximal to Achilles insertion point, combined with eccentric heel drops and gradual return to running

A., Thorburn, A

Talk to your doctor first

Synergistic Oral Complex for Recovery, Balance &amp